ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2022

Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies.

Fioravante Capone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.